BRIEF-Nxera Pharma Co Ltd - Nxera To Receive Us$4.8 Mn In Milestone Payments Following Centessa's Initiation Of Clinical Development Of Orx142, A Novel Ox2r Agonist

Reuters · 07/04 00:02

Please log in to view news